5621 — Human Technologies Income Statement
0.000.00%
- ¥19bn
- ¥16bn
- ¥6bn
- 84
- 25
- 80
- 71
Annual income statement for Human Technologies, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 3,585 | 4,223 | 5,035 | 6,055 |
Cost of Revenue | ||||
Gross Profit | 2,634 | 2,999 | 3,418 | 4,184 |
Selling / General / Administrative Expenses | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 2,976 | 3,898 | 4,515 | 5,125 |
Operating Profit | 608 | 326 | 520 | 931 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | 602 | 326 | 501 | 935 |
Provision for Income Taxes | ||||
Net Income After Taxes | 439 | 238 | 335 | 655 |
Net Income Before Extraordinary Items | ||||
Net Income | 439 | 238 | 335 | 655 |
Adjustments to Net Income | ||||
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | 439 | 238 | 335 | 655 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | 46.9 | 26.4 | 35 | 68.3 |
Dividends per Share |